NeuroScientific Biopharmaceuticals Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

neuroscientific.com

Country

Australia

Exchange

ASX

NeuroScientific Biopharmaceuticals provides the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma.

It also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.

Key Stats

52-Week Range

A$0.06A$0.25

Beta1.12

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.02

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$0.43

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.